Where our team of guest writers discuss what they think about the current NGP US Issues.
Drug discovery needs all the help it can get. NGP talks problems and solutions with four gene genies: IQuum’s Shuqi Chen, Sequenom’s Elizabeth Dragon, Cellumen’s D. Lansing Taylor, and X from Assuragen.
The use of new technologies to overcome many of the initial challenges in microRNA research will allow comprehensive studies of microRNA expression patterns and identification of microRNA biomarkers in cancer and other diseases over the next few year
Few medicinal chemists know that the palladium-catalyzed cross-coupling of organoboron compounds was observed in 1978 by Ei-Ichi Negishi.
DNA Accessibility Now Drives Genomic Medicine and Identification
In recent years, proteomic technologies have led to enormous advances in basic research and medicine. The impact that these technologies can have on a more complete understanding of the processes of life is only now beginning to be realized.